Medpace Holdings (MEDP) Non-Current Deferred Tax Liability (2015 - 2026)
Medpace Holdings' (MEDP) quarterly Non-Current Deferred Tax Liability came in at $8.2 million in Q2 2026, up 307.09% YoY from $2.0 million in Q2 2025, and up 109.1% on a QoQ basis from $3.9 million in Q1 2026.
Medpace Holdings (MEDP) Non-Current Deferred Tax Liability (2015 - 2026) Analysis & Trends
Medpace Holdings (MEDP) has 12 years of Non-Current Deferred Tax Liability data on file, last reported at $8.2 million in Q2 2026.
- Quarterly Non-Current Deferred Tax Liability rose 307.09% year-over-year to $8.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $8.2 million (up 307.09% YoY) and the FY2025 annual result came in at $1.4 million, down 97.82% from the prior year.
- Non-Current Deferred Tax Liability grew to $8.2 million in Q2 2026, from $3.9 million in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $62.1 million in Q4 2024 to a low of $911000.0 in Q3 2022.
- A 5-year average of $11.0 million and a median of $2.0 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
- Annual changes were most pronounced in 2025 — Non-Current Deferred Tax Liability plunged 97.82% — and 2026, when it jumped 307.09%.
- Tracing MEDP's Non-Current Deferred Tax Liability over 5 years: stood at $47.1 million in 2022, then grew by 17.64% to $55.4 million in 2023, then climbed by 12.04% to $62.1 million in 2024, then sank by 97.82% to $1.4 million in 2025, then jumped by 505.68% to $8.2 million in 2026.
- The last three Non-Current Deferred Tax Liability figures came in at $8.2 million (Q2 2026), $3.9 million (Q1 2026), and $1.4 million (Q4 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.88 Bn | 209.81 Bn | 8.34 Bn |
| 2 | Danaher | 140.65 Bn | 136.30 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.02 Bn | 45.83 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.85 Bn | 38.05 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.20 Bn | 37.12 Bn | 1.44 Bn |
| 6 | Natera | 38.80 Bn | 37.70 Bn | 696.04 Mn |
| 7 | Illumina | 30.11 Bn | 28.94 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.66 Bn | 28.61 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.24 Bn | 25.61 Bn | 1.03 Bn |
| 10 | Medpace Holdings | 16.54 Bn | 16.03 Bn | 201.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 8.21 Mn |
| Jun 30, 2026 | 8.21 Mn |
| Mar 31, 2026 | 3.93 Mn |
| Mar 31, 2026 | 3.93 Mn |
| Dec 31, 2025 | 1.36 Mn |
| Dec 31, 2025 | 1.36 Mn |
| Sep 30, 2025 | 1.90 Mn |
| Sep 30, 2025 | 1.90 Mn |
| Jun 30, 2025 | 2.02 Mn |
| Jun 30, 2025 | 2.02 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Mar 31, 2025 | 1.84 Mn |
| Dec 31, 2024 | 62.12 Mn |
| Dec 31, 2024 | 62.12 Mn |
| Sep 30, 2024 | 2.29 Mn |
| Sep 30, 2024 | 2.29 Mn |
| Jun 30, 2024 | 2.29 Mn |
| Jun 30, 2024 | 2.29 Mn |
| Mar 31, 2024 | 2.36 Mn |
| Mar 31, 2024 | 2.36 Mn |